FrederickFeitMD
Cardiology • New York, NYAdult Congenital Heart Disease, Interventional Cardiology
Associate Professor, Medicine, New York University School of Medicine
Dr. Feit is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
550 1st Ave
Th 576
New York, NY 10016Phone+1 212-263-5656
Education & Training
NYU Grossman School of MedicineResidency, Physical Medicine and Rehabilitation, 1982 - 1983- NYU Grossman School of MedicineFellowship, Interventional Cardiology, 1977 - 1978
- NYU Grossman School of MedicineResidency, Internal Medicine, 1973 - 1978
- New York University School of MedicineClass of 1972
Certifications & Licensure
NY State Medical License 1973 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- Top Doctors: New York Metro Area Castle Connolly, 2014
- Super Doctor SuperDoctors.com
- Fellow (FACC) American College of Cardiology
Clinical Trials
- Thrombolysis in Myocardial Infarction (TIMI) Start of enrollment: 1983 Apr 01
Publications & Presentations
PubMed
- 58 citationsImpact of chronic kidney disease on early (30-day) and late (1-year) outcomes of patients with acute coronary syndromes treated with alternative antithrombotic treatme...Roxana Mehran, Eugenia Nikolsky, Alexandra J. Lansky, Ajay J. Kirtane, Young-Hak Kim
JACC. Cardiovascular Interventions. 2009-08-01 - 103 citationsEffects of Acute Colchicine Administration Prior to Percutaneous Coronary Intervention: COLCHICINE-PCI Randomized TrialBinita Shah, Michael H. Pillinger, Hua Zhong, Bruce N. Cronstein, Yuhe Xia
Circulation. Cardiovascular Interventions. 2020-04-16 - 170 citationsNewer-Generation Ultrathin Strut Drug-Eluting Stents Versus Older Second-Generation Thicker Strut Drug-Eluting Stents for Coronary Artery Disease.Sripal Bangalore, Bora Toklu, Neil Patel, Frederick Feit, Gregg W. Stone
Circulation. 2018-11-13
Press Mentions
Safe to Skip Post-TAVR Clopidogrel in Patients on OAC for Atrial Fib: POPULAR-TAVIMarch 31st, 2020
AFib Patients Better off with No Antiplatelet After TAVRMarch 29th, 2020
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
